Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Karl Mikael Kälkner"'
Autor:
Karl-Mikael Kälkner, Anders Sundström, Maria Juhasz Haverinen, Kenneth Nordback, Veronica Arthurson, Björn Zethelius, Rickard Ljung
Publikováno v:
Upsala Journal of Medical Sciences, Vol 128, Pp 1-5 (2023)
Background: Chloroquine and hydroxychloroquine (C/HC) received considerable international media attention due to anticipated treatment effect in COVID-19. This led to increased prescriptions threatening to generate product shortages for patients pres
Externí odkaz:
https://doaj.org/article/bdc12e9fe65143399ea49652e5c73942
Autor:
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Publikováno v:
Drug Safety. 46:319-321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48b81b4fbf370de2e28e039692cf61d5
https://doi.org/10.1007/s40264-023-01275-7
https://doi.org/10.1007/s40264-023-01275-7
Publikováno v:
Lakartidningen. 117
The Medical Products Agency (MPA) has conducted the assessment presented in this manuscript within the remits of a Government assignment to the MPA. No new safety concern, and consequently no need for regulatory action, has been identified in relatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a3471feccfc0ee7f9c2904a7931610a
https://pubmed.ncbi.nlm.nih.gov/32430902
https://pubmed.ncbi.nlm.nih.gov/32430902
Autor:
Karl-Mikael Kälkner, Marie Hjälm-Eriksson, Sten Nilsson, Hemming Johansson, Seymoure Levitt, Anders Ullén
Publikováno v:
Acta Oncologica. 56:21-26
The risk stratification currently applied prior to curative treatment for localized prostate cancer (PC) does not take into account comorbidity or age. Therefore, we investigated the impact of comorbidity on overall survival (OS) in PC patients treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879921649e853c321ced79858742b13c
https://doi.org/10.1080/0284186x.2016.1253864
https://doi.org/10.1080/0284186x.2016.1253864
Autor:
Bo Lennernäs, Hans Lennernäs, Ingela Frank-Lissbrant, Rob Derrick, Julian Howell, Karl Mikael Kälkner
Publikováno v:
Palliative Medicine. 24:286-293
In this study we evaluated the efficacy and tolerability of sublingual fentanyl (SLF) for breakthrough pain (BTP) in adult opioid-tolerant cancer patients. Patients received one dose of placebo, SLF 100, 200 and 400 μg in random order at four pain e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3caa6ae39ff43f7f6c979e0933c2e066
https://doi.org/10.1177/0269216309356138
https://doi.org/10.1177/0269216309356138
Autor:
Carina Holmberg, Josef Nilsson, Sten Nilsson, Karl Mikael Kälkner, Lars Berg, Marie Lundell, Seymour H. Levitt
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 71:36-40
Purpose To investigate the accuracy and the dosimetric consequences of substituting a surrogate urethra assumed to be at the geometric center of the prostate, in place of the true urethra when using high-dose-rate (HDR) brachytherapy for the treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d83ea8796d3e216cc04bb3d8a9aa92
https://doi.org/10.1016/j.ijrobp.2007.09.025
https://doi.org/10.1016/j.ijrobp.2007.09.025
Autor:
Seymour H. Levitt, Sten Nilsson, Marie Lundell, Carina Holmberg, Karl Mikael Kälkner, Emil Bengtsson, Simone Eriksson
Publikováno v:
Brachytherapy. 6:49-52
PURPOSE: The objective of this study is to determine the radiation dose to the anus during bra- chytherapy using high-dose-rate Ir-192 sources. METHODS AND MATERIALS: Thermoluminescence dosimeters were used for measuring the dose to the distal part o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c545c15ec9d1b6e7bc8fbc5c3ca7c0b
https://doi.org/10.1016/j.brachy.2006.08.008
https://doi.org/10.1016/j.brachy.2006.08.008
Autor:
Henric Blomgren, Ingmar Lax, Pavel Pisa, Karl-Mikael Kälkner, Christer Svedman, Peter Wersäll
Publikováno v:
Acta Oncologica. 45:493-497
To the EditorThe treatment options in renal cancer are few and the response rates are low. It is also a cancer form that has a diverse biology-the vast majority of cases progress rapidly but in a s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e8d5a44802bcda2d4d6753b361dcd92
https://doi.org/10.1080/02841860600604611
https://doi.org/10.1080/02841860600604611
Autor:
Pavel Pisa, Karl-Mikael Kälkner, Peter Wersäll, Henric Blomgren, Per Sandström, Ingemar Lax, Christer Svedman, Sten Nilsson
Publikováno v:
Acta Oncologica. 45:870-875
A retrospective study has indicated that stereotactic radiotherapy (SRT) has a value in treating both primary tumors and singular metastatic lesions that cause local symptoms. Here we present the results of a prospective study evaluating the safety a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbafb3d566e55cd745bd123164e9795
https://doi.org/10.1080/02841860600954875
https://doi.org/10.1080/02841860600954875
Autor:
Ulrika Harmenberg, Marie Hjelm-Eriksson, Karl Mikael Kälkner, Lena Lennartsson, Anders Ullén, Bo Lennernäs, Sten Nilsson
Publikováno v:
Acta Oncologica. 44:644-650
Once bone metastasized and androgen independent, prostate cancer is often associated with skeletal morbidity and disability. New treatment modalities that can palliate symptoms from the skeleton and inhibit further progression are warranted. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65225c69303176e10dfb1b401e130378
https://doi.org/10.1080/02841860510029617
https://doi.org/10.1080/02841860510029617